Finally, glucagon or GLP-1 receptor agonists have been combined with hormone nuclear receptor agonists for estrogens, androgens, and thyroid hormones, as the activation of their nuclear receptors is known to induce beneficial effects for metabolic syndrome. This evidence concerns the gene TG and metabolic syndrome.